These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17159521)

  • 21. Malignancy in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
    McDonald-McGinn DM; Reilly A; Wallgren-Pettersson C; Hoyme HE; Yang SP; Adam MP; Zackai EH; Sullivan KE
    Am J Med Genet A; 2006 Apr; 140(8):906-9. PubMed ID: 16532473
    [No Abstract]   [Full Text] [Related]  

  • 22. Chromosome 22q11.2 deletion syndrome: DiGeorge syndrome/velocardiofacial Syndrome.
    Sullivan KE
    Immunol Allergy Clin North Am; 2008 May; 28(2):353-66. PubMed ID: 18424337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical heterogeneity of the chromosome 22q11 microdeletion syndrome].
    Muñoz S; Garay F; Flores I; Heusser F; Talesnik E; Aracena M; Mellado C; Méndez C; Arnaiz P; Repetto G
    Rev Med Chil; 2001 May; 129(5):515-21. PubMed ID: 11464533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Small deletion--large effect].
    Lüerssen K; Pruggmayer M; Ptok M
    HNO; 2004 Mar; 52(3):258-60. PubMed ID: 15004686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The DiGeorge anomaly (CATCH 22, DiGeorge/velocardiofacial syndrome).
    Hong R
    Semin Hematol; 1998 Oct; 35(4):282-90. PubMed ID: 9801257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Microdeletion of 22q11, DiGeorge and velocardiofacial syndrome].
    Hjalgrim H; Hahnemann JM; Timshel S; Brøndum-Nielsen K
    Ugeskr Laeger; 2000 Jul; 162(31):4169-70. PubMed ID: 10962926
    [No Abstract]   [Full Text] [Related]  

  • 27. Is isolated palatal anomaly an indication to screen for 22q11 region deletion?
    Reish O; Finkelstein Y; Mesterman R; Nachmani A; Wolach B; Fejgin M; Amiel A
    Cleft Palate Craniofac J; 2003 Mar; 40(2):176-9. PubMed ID: 12605524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic basis of DiGeorge and velocardiofacial syndromes.
    Driscoll DA
    Curr Opin Pediatr; 1994 Dec; 6(6):702-6. PubMed ID: 7849818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allergies in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) and patients with chronic granulomatous disease.
    Staple L; Andrews T; McDonald-McGinn D; Zackai E; Sullivan KE
    Pediatr Allergy Immunol; 2005 May; 16(3):226-30. PubMed ID: 15853951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical utility gene card for: DiGeorge syndrome, velocardiofacial syndrome, Shprintzen syndrome, chromosome 22q11.2 deletion syndrome (22q11.2, TBX1).
    Schwinger E; Devriendt K; Rauch A; Philip N
    Eur J Hum Genet; 2010 Sep; 18(9):. PubMed ID: 20125192
    [No Abstract]   [Full Text] [Related]  

  • 31. Velo-cardio-facial and DiGeorge syndromes with meningomyelocele and deletions of the 22Q11 region.
    Nickel RE; Pillers DA; Merkens M; Magenis RE; Driscoll DA; Emanuel BS; Zonana J
    Eur J Pediatr Surg; 1993 Dec; 3 Suppl 1():27-8. PubMed ID: 8130147
    [No Abstract]   [Full Text] [Related]  

  • 32. 22q11.21 Deletion Syndromes: A Review of Proximal, Central, and Distal Deletions and Their Associated Features.
    Burnside RD
    Cytogenet Genome Res; 2015; 146(2):89-99. PubMed ID: 26278718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of 22q11.2 deletion among 139 patients with Di George/Velocardiofacial syndrome features.
    Kitsiou-Tzeli S; Kolialexi A; Fryssira H; Galla-Voumvouraki A; Salavoura K; Kanariou M; Tsangaris GT; Kanavakis E; Mavrou A
    In Vivo; 2004; 18(5):603-8. PubMed ID: 15523900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is the autosomal dominant Optiz GBBB syndrome part of the DiGeorge/velocardiofacial syndrome with deletions of chromosome area 22q11.2?
    Wulfsberg EA
    Am J Med Genet; 1996 Aug; 64(3):523-4. PubMed ID: 8862634
    [No Abstract]   [Full Text] [Related]  

  • 35. 22q11.2 distal deletion: a recurrent genomic disorder distinct from DiGeorge syndrome and velocardiofacial syndrome.
    Ben-Shachar S; Ou Z; Shaw CA; Belmont JW; Patel MS; Hummel M; Amato S; Tartaglia N; Berg J; Sutton VR; Lalani SR; Chinault AC; Cheung SW; Lupski JR; Patel A
    Am J Hum Genet; 2008 Jan; 82(1):214-21. PubMed ID: 18179902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The velo-cardio-facial syndrome: the otorhinolaryngeal manifestations and implications.
    Vantrappen G; Rommel N; Cremers CW; Devriendt K; Frijns JP
    Int J Pediatr Otorhinolaryngol; 1998 Oct; 45(2):133-41. PubMed ID: 9849681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The 22q11.2 deletion syndrome.
    Emanuel BS; McDonald-McGinn D; Saitta SC; Zackai EH
    Adv Pediatr; 2001; 48():39-73. PubMed ID: 11480765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mice overexpressing genes from the 22q11 region deleted in velo-cardio-facial syndrome/DiGeorge syndrome have middle and inner ear defects.
    Funke B; Epstein JA; Kochilas LK; Lu MM; Pandita RK; Liao J; Bauerndistel R; Schüler T; Schorle H; Brown MC; Adams J; Morrow BE
    Hum Mol Genet; 2001 Oct; 10(22):2549-56. PubMed ID: 11709542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CATCH 22 Syndrome.
    Yonehara Y; Nakatsuka T; Ichioka S; Sasaki N; Kobayashi T
    J Craniofac Surg; 2002 Sep; 13(5):623-6. PubMed ID: 12218787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 22q11.2 deletion syndrome: DiGeorge, velocardiofacial, and conotruncal anomaly face syndromes.
    Cuneo BF
    Curr Opin Pediatr; 2001 Oct; 13(5):465-72. PubMed ID: 11801894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.